This opening plenary of the Making Self-Injection Count workshop highlighted how self-injection data can help close the gender data gap by providing key information and insights on the experiences of women and adolescents. Presenters discussed how self-injection can contribute to contraceptive autonomy by enabling women and girls to make and actualize their own decisions. The session featured personal stories from a self-injection ambassador, self-injection provider, and self-injection client.
By the end of this session, participants were able to:
- Describe the importance of self-injection for contraceptive autonomy, and self-injection in the context of self-care.
- Describe the landscape of self-injection data availability.
- Understand experiences of self-injection from the lens of a provider, user, and advocate.
- While progress is being made, self-injection data availability is still limited compared to other contraceptive data sets.
- Disaggregation by client age, district, and DMPA-SC delivery mode (self-injected vs. provider-administered DMPA-SC) is essential to DMPA-SC data tracking.
- High-quality data systems give us insight into women’s and girls’ preferences, client access to family planning, provider training needs, and global supply management opportunities.
- Caitlin Corneliess, MPH, Project Director, DMPA-SC Access Collaborative
- Fannie Kachale, Director Reproductive Health Services, Ministry of Health, Malawi
- Briana Lucido, WHO Department of Sexual and Reproductive Health and Research
- Dr. George Swomen, MD, Programme Officer of Special Projects, Planned Parenthood Federation of Nigeria (PPFN)
- Fatimata Deme, President, Senegalese Women’s Network for the Promotion of Family Planning
- Matilda, Volunteer, Kibalinga Health Centre in Uganda